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Abstract: Health-related quality of life (HRQoL) is a key measure for evaluating health status in
populations. Using the recent EQ-5D-5L for measurement, this study analyzed quality of life results
and their stability over consecutive population surveys. Three cross-section surveys for representative
samples of the general German population from 2012, 2013, and 2014 were evaluated using the
EQ-5D-5L descriptive system and valuation by the Visual Analog Scale (VAS). Aggregated sample
size reached 6074. The dimension with the highest prevalence of problems was pain/discomfort
(31.7%). Compared with 2012 (59.3%), the percentage of participants in the best health state increased
slightly in 2013 (63.4%) and 2014 (62%). Over the 3-year period, diabetes and heart disease had
the strongest negative influence on mean VAS result. The number of reported chronic diseases
cumulatively reduced mean VAS. Extreme problems in one or more dimensions were stated by only
0.1%–0.2% of patients. Of the potential 247 health states with a problem score ě20, only six were
observed in the aggregated sample. HRQoL results were fairly stable over the 3 years, but the share of
the population with no problems was not. Results from the aggregated sample may serve as updated
reference values for the general German population.
Keywords: EQ-5D-5L; cross-section; reference values; Germany
1. Introduction
Health-related quality of life (HRQoL) is one key measure for the effectiveness and
cost-effectiveness of healthcare interventions. HRQoL can be measured by different instruments
including the EuroQol five-dimension questionnaire (EQ-5D) [1]. The EQ-5D is a well-accepted and
widely used measure. Its use, quantified by PubMed search results, has steadily increased on a year
by year basis since 1992 [2]. The EQ-5D is one of the psychometric approaches and is a descriptive
generic instrument. It consists of five dimensions (mobility, self-care, usual activity, pain/discomfort,
anxiety/depression) and a visual analog scale (VAS). The VAS is a continuous response scale that
ranges from 0 (worst state) to 100 (best state). Responders rate their current health state by selecting
a point on this scale. The 3L version of the EQ-5D includes three answer levels for each of the five
dimensions, ranging from no problems (1) to some problems (2) to extreme problems (3). The newer
5L version incorporates five answer levels (1–5), with additional slight as well as severe problem
categories, and was introduced in 2011 [3]. The best health state is depicted by 11111 and the worst
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by 55555. The advantages of the EQ-5D-5L compared with 3L include reduced ceiling effects [4,5],
increased level of detail [6], and more discriminatory power while establishing convergent groups
and their respective validity [7,8]. The responses for each dimension deliver a profile, which is then
valued by VAS, but VAS results are also usually reported when no valuation is done. Alternatively,
a population-based value set may be used. Examples of derived and well-accepted value sets that
generate utilities by time trade-off valuation of given health states for the 3L version include those
by Dolan 1997 [9] for the UK or Greiner et al. 2005 [10] for Germany; other value set concepts are
based on experienced health such as those for Sweden [11] and Germany [12]; value sets for the 5L
version are under development [13] and currently only available for England, Japan, Canada, and
Uruguay [14]. This study only considers the VAS valuation of their own health state by respondents,
thus establishing their perspective on quality of life.
Longitudinal data are harder to obtain but also have certain disadvantages over cross-sectional
data, including correlation of observations among one individual. Thus, they require sophisticated
handling [15]. Typically [16], general population surveys using the EQ-5D are conducted as single
cross-sectional surveys and are eventually repeated after several years. Using single-year samples
usually assumes stability of the results found and, for many survey parameters, sample sizes ensure
this assumption in well-designed studies. Empirically, however, temporal stability of the results of
such cross-sectional studies has hardly been investigated. Focusing on this research gap, the aim of
the study is to analyze the results of three EQ-5D-5L surveys conducted in 2012, 2013, and 2014 by
focusing especially on variation in results of health state descriptions and valuations, including the role
of sociodemographic parameters and one important determinant of HRQoL, chronic diseases [17,18].
Results are compared with previous surveys using the 3L version, and may lead to updated reference
values of the 5L version for the general German population.
2. Methods
2.1. Data Sampling
Quality of life measured by the EQ-5D is an add-on component to a yearly survey of the general
German population that is conducted by the IFAK research institute on behalf of the Wort & Bild Verlag.
Results from earlier add-on studies using the EQ-5D-3L have been published elsewhere [12,18,19].
The Wort & Bild survey uses a random-route procedure to randomly select a sample of the German
population aged 14 years and older. The sampling system contained over 53,000 sample points with
a minimum of 350 households per point. On average, the sample points included 700 households.
The sample points were layered according to region and the Germany specific BIK code, a geographic
and demographic classification system. To achieve representability 516 sample points were randomly
chosen from these layers. The interviewers were equipped with a starting address in these sample
points and had to follow randomly chosen routing information. They were instructed to ask for
participation at every fifth household on this route, until five surveys were completed. Household
members were selected based on a Kish selection grid, and were asked for consent to take part in the
survey. Response rates were high at 72.6% in 2012, 71.8% in 2013, and 70.3% in 2014. The main reason
for non-responsiveness was the absence of household members. Over 2000 surveys were completed
each year. The survey data, collected in 2012, 2013, and 2014, were quite representative of the German
population (see supplementary Table S1). Thus, weights were not applied for the purpose of this
study. Sociodemographic parameters, health status, and distribution-based data were also extracted
for this add-on study. Disease affliction is based on open-ended self-report; participants stated which
diseases they suffered from during the last 3 months and whether these were chronic. Only the five
most prevalent diseases in the total sample were evaluated for the purpose of this study.
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2.2. Data Analysis
Descriptive methods were used to analyze the majority of data. Chi-square tests were used to
evaluate frequency differences between survey years. Analysis of variance (ANOVA) was used to
determine estimators for VAS reduction stratified by disease. All analyses, including problem score
evaluation, are based on the statistical software package SAS 9.3 (SAS Institute Inc., Cary, NC, USA).
Figures were created by using the package ggplot2 [20], version 2.0.0 (Hadley Wickham), for the
software environment R [21], version 3.2.2 (R Foundation for Statistical Computing, Vienna, Austria).
3. Results
3.1. Study Sample
Table 1 shows the basic characteristics of the three evaluated samples. EQ-5D-5L data were
available for 6074 people (2012: 2045; 2013: 2028; 2014: 2001), who were included in the analysis.
In total, 52.9% of the participants were female. The average age was 47.1 years. The participants from
2013 (45.9 years mean age) were about 1.5 years younger than the participants from 2012 and 2013,
which is indicated by fewer people in the age groups from 60 years onward. The number of people
living alone stayed nearly the same, and a slight shift toward better education could be observed.
The number of people with low education (high school with and without apprenticeship) decreased,
whereas the number of people with medium (middle school) and high education (grammar school
with and without university attendance) increased slightly. Missing education or living status data did
not exclude participants from further analysis regarding HRQoL.
Table 1. Study population, education, and living status.
Parameters 2012 2013 2014 All
Mean age (years) 47.6 45.9 47.4 47.0
Male 977 (47.8) 950 (46.8) 932 (46.6) 2859 (47.1)
Female 1068 (52.2) 1078 (53.2) 1069 (53.4) 3215 (52.9)
Education *
Low 854 (43.2) 733 (37.7) 730 (38.0) 2317 (39.7)
Medium 716 (36.2) 806 (41.5) 777 (40.5) 2299 (39.4)
High 409 (20.7) 404 (20.8) 412 (21.5) 1225 (21.0)
Living alone
No 1159 (58.6) 1126 (58.0) 1135 (59.1) 3420 (58.6)
Yes 820 (41.4) 817 (42.0) 784 (40.9) 2421 (41.4)
Numbers as absolute values. Percentage in parentheses, if appropriate. * p < 0.05, chi-square test for statistically
significant differences over the 3-year period.
3.2. EQ-5D Distribution
EQ-5D-5L-related answer frequencies based on dimension are depicted in Table 2. The dimension
with the least reported problems was self-care, followed by usual activity and anxiety/depression
as well as mobility. In contrast, a high proportion or around one third of participants experienced
problems with pain/discomfort. The chi-square test for statistical differences among the 3 years
yielded a significant p-value (p = 0.04) only for pain/discomfort. The participants from 2013 and 2014
suffered from significantly fewer problems in this dimension.
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Table 2. Answer frequencies based on dimension, aggregated sample.
Level Mobility Self-Care Usual Activity Pain/Discomfort Anxiety/Depression
1 4998 (82.3) 5712 (94.0) 5274 (86.8) 4149 (68.3) 4987 (82.1)
2 656 (10.8) 260 (4.3) 567 (9.3) 1301 (21.4) 799 (13.2)
3 304 (5.0) 79 (1.3) 180 (3.0) 521 (8.6) 236 (3.9)
4 107 (1.8) 19 (0.3) 46 (0.8) 91 (1.5) 45 (0.7)
5 9 (0.1) 4 (0.1) 7 (0.1) 12 (0.2) 7 (0.1)
Percentage in parentheses. Level 1: no problems; 2: slight problems; 3: moderate problems; 4: severe problems;
5: extreme problems.
3.3. Problem Score Data
The problem score (Table 3) aggregates the manifestations of each dimension by adding up the
five answer levels into one number. In total, 3125 health states are possible for the EQ-5D-5L, but only
265 different health states were observed in our samples. An increasing problem score correlated with
a decreasing number of actual observations. The problem scores ď12 cover around 97% of participants,
whereas the number of possible health states increases up to problem score 15. The number of realized
different health states peaked at problem score 10. Calculating the overall p-value (chi-square test) for
the influence of year on problem score delivered no significant result (p = 0.2165).
Table 3. Problem score distribution.
Problem Score Possible States 2012 2013 2014 All
5 1 1213 (59.3) 1286 (63.4) 1240 (62) 3739 (61.6)
6 5 261 (12.8) 270 (13.3) 270 (13.5) 801 (13.2)
7 15 195 (9.5) 154 (7.6) 163 (8.1) 512 (8.4)
8 35 104 (5.1) 90 (4.4) 85 (4.2) 279 (4.6)
9 70 76 (3.7) 67 (3.3) 73 (3.6) 216 (3.6)
10 121 53 (2.6) 48 (2.4) 45 (2.2) 146 (2.4)
11 185 48 (2.3) 37 (1.8) 39 (1.9) 124 (2.0)
12 255 27 (1.3) 25 (1.2) 28 (1.4) 80 (1.3)
13 320 31 (1.5) 14 (0.7) 22 (1.1) 67 (1.1)
14 365 8 (0.4) 11 (0.5) 14 (0.7) 33 (0.5)
15 381 5 (0.2) 9 (0.4) 9 (0.4) 23 (0.4)
16 365 8 (0.4) 1 (0.0) 7 (0.3) 16 (0.3)
17 320 6 (0.3) 5 (0.2) 3 (0.1) 14 (0.2)
18 255 3 (0.1) 6 (0.3) 2 (0.1) 11 (0.2)
19 185 4 (0.2) 2 (0.1) 1 (0) 7 (0.1)
20 121 3 (0.1) 1 (0.0) - 4 (0.1)
21 70 - 1 (0.0) - 1 (0.0)
22 35 - - - 0 (0.0)
23 15 - - - 0 (0.0)
24 5 - 1 (0.0) - 1 (0.0)
25 1 - - - -
All 3125 2045 2028 2001 6074
Numbers as absolute values. Percentage in parentheses, if appropriate.
3.4. Most Prevalent Health States
A majority of 61.6% stated that they had no problems (11111) in all five dimensions of the EQ-5D
(Table 4). This manifestation was strongest—probably because of mean age difference—in 2013 at
63.4% and lowest in 2012 at 59.3%. The 11111 state is followed by 8.3% of participants reporting
slight problems in the pain/discomfort dimension (11121) and 4.1% reporting slight problems in the
anxiety/depression dimension (11112). The 11121 state dropped 0.7 percentage points from 2012 to
2014. At the same time, the 11112 state increased 1.3 percentage points from 2012 to 2014. However,
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the only significant differences between the 3 years were seen for the optimal health state and 11122
(slight problems with pain/discomfort and anxiety/depression). Figure 1 illustrates the percental
decline over age groups in the share of respondents not reporting any problem. While around 90% of
adolescents state to be in the optimal health state, only around 8% do so in the age group 80+.
Table 4. Frequencies of most reported health states.
Health States 2012 2013 2014 All
11111 * 1213 (59.3) 1286 (63.4) 1240 (62.0) 3739 (61.6)
11121 178 (8.7) 167 (8.2) 160 (8.0) 505 (8.3)
11112 69 (3.4) 83 (4.1) 95 (4.7) 247 (4.1)
11122 * 75 (3.7) 43 (2.1) 53 (2.6) 171 (2.8)
21121 51 (2.5) 52 (2.6) 61 (3.0) 164 (2.7)
21221 29 (1.4) 21 (1.0) 28 (1.4) 78 (1.3)
11113 23 (1.1) 13 (0.6) 16 (0.8) 52 (0.9)
11131 26 (1.3) 15 (0.7) 13 (0.6) 54 (0.9)
Others 381 (18.6) 348 (17.2) 335 (16.7) 1064 (17.5)
Percentage in parentheses; * p < 0.05, chi-square test for statistically significant differences among all
3 years. Coding of health states: 1 = no problem; 2 = slight problems; 3 = some problems; 4 = severe
problems; 5 = extreme problems. 1st digit: mobility; 2nd digit: self-care; 3rd digit: usual activities; 4th digit:
pain/discomfort; 5th digit: anxiety/depression.
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the perception of health on the day of the survey. The reported VAS values become smaller with 
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Figure 1. Percentage of respective age group without problem (EQ-5D-5L descriptive score: 11111),
aggregated sample.
3.5. VAS
Figure 2 illustrates VAS means stratified by whether or not any problem was reported in the five
descriptive dimensions of the EQ-5D. “No problem” refers to all 3739 participants with a score of 11111
and scores >11111 are referred to as “at least one problem reported”. Participants with no problem had
a mean VAS score of 91.86. “Irrespective of problem” depicts the whole sample of 6074 participants.
The VAS mean for all participants was 84.3 (women: 83.1; men: 85.7). It should be noted that EQ-5D
scores do not imply the presence or absence of self-reported disease; they only measure the perception
of health on the day of the survey. The reported VAS values become smaller with increasing age.
Significant divergence is present for people with problems and those without. From age groups 10–19
to 70–79 years, the difference between both groups amounts to around 20 points. From age group
70–79 to 80+ years, a big decrease of around 10 points is observed for the problem group, whereas the
group without problems deteriorates only by around 2.5 points. This resembles a rapid and significant
worsening of the average respondent’s perception of their health status after age 75. The number
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of people with no problems (n = 3739) decreases continuously. In the age group 80+ years, fewer
than 10% report no problems. Compared with men, women tend to have slightly lower VAS means
from age groups 20–75 years and slightly higher means from around 75 years onward (not shown).
The differences in the decrease in HRQoL between all three surveys and respective age groups are
significant (p = 0.0072). Detailed results are available from the authors.
VAS values by age and sex group for the aggregated sample are reported in supplementary
Table S2 and may be used as reference values.
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Figure 2. VAS means based on age group, stratified by optimal and non-optimal health state, aggregated
sample. No problem reported shows the average VAS score for the subsample of participants with
a descriptive score of 11111 (n = 3739). At least one problem reported refers to the subsample of
remaining participants with at least one dimension score >1 (n = 2335). Irrespective of problem depicts
the whole sample (n = 6074).
3.6. Disease Affliction and Influence on HRQoL
Besides reporting problems in the EQ-5D dimensions participants were also asked to state their
current chronic diseases. Compared with 2012 and 2014, participants from 2013 reported the lowest
percentage of disease affliction, except for rheumatism at 1.6% in 2013 and 2014 (Table 5). This is likely
to be rooted in the fact that the average age in the sample from 2013 was lower than in the other two
samples. Overall, 4.4% stated that they suffered from musculoskeletal disease, 6.1% from hypertension,
3.2% from diabetes, 1.9% from heart disease, and 1.5% from rheumatism. From the total sample, only
a minority of around 14% stated to suffer from at least one of these diseases.
Chi-square tests were used to determine statistically significant differences for the evaluated
parameters in Table 5 across survey years, but none were found.
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Table 5. Prevalence of diseases.
Disease 2012 2013 2014 All
Musculoskeletal disease 97 (4.7) 83 (4.1) 85 (4.2) 265 (4.4)
Hypertension 138 (6.7) 108 (5.3) 127 (6.3) 373 (6.1)
Diabetes 67 (3.3) 63 (3.1) 66 (3.3) 196 (3.2)
Heart disease 39 (1.9) 34 (1.7) 44 (2.2) 117 (1.9)
Rheumatism 28 (1.4) 32 (1.6) 32 (1.6) 92 (1.5)
Four or more diseases 0 (0) 2 (0.1) 3 (0.1) 5 (0.1)
Three diseases 6 (0.3) 4 (0.2) 4 (0.2) 14 (0.2)
Two diseases 50 (2.4) 46 (2.3) 58 (2.3) 154 (2.5)
One disease 251 (12.3) 208 (10.3) 214 (10.7) 673 (11.1)
Percentage in parentheses. No statistically significant differences found over the 3-year period (chi-square test,
p < 0.05).
Thus, we evaluated the influence of diseases on HRQoL by aggregated sample. Figure 3 depicts
the average reduction in VAS values (based on ANOVA) when disease is present. From a quantitative
perspective, the presence of two diseases has a stronger negative influence on VAS mean than any of
the single diseases. Due to the low number of observations for three and four diseases, the confidence
intervals are very wide. Group affiliation (yes/no) was the only classification variable in this model.
The widths of the 95% confidence intervals corresponded to the prevalence of the observed parameter.
The higher the prevalence, the smaller the confidence interval. The VAS mean for having no chronic
disease was 87.1 compared with 84.3 for the whole sample. Diabetes had the strongest negative
influence on mean VAS value and led to a mean reduction of around 24.4 points. Of the five evaluated
diseases, musculoskeletal disease had the lowest delta of around ´16.8. The differences for the
reduction in VAS means by disease, between years, were not significant (not shown, detailed results
available from the authors). The reductions seem clinically relevant as they all exceed the minimal
important differences that were identified for the EQ-5D in patients with back pain, early rheumatoid
arthritis, or myocardial infarction [22].
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4. Discussion
We found that the percentage of people in the optimal health state increased from 59.3% in 2012 to
63.4% and 62% in 2013 and 2014 respectively. This variation over all 3 years was significant (p < 0.02),
but may be linked to the variation in sociodemographic data across the samples. To confirm this
possible trend toward better health, more EQ-5D-5L data and especially follow-up evaluations are
needed in future. Our results indicate that the survey approach, including the random-route selection
process, is not suitable to deliver sufficient data for participants with extreme problems. It became
apparent that sample sizes of 2000 participants, if selected by random-route procedures as in this study,
are sufficient to analyze EQ-5D-5L data for problem scores ranging from 1 to 10 or even 15 but lack
sufficient observations for higher scores. Only 0.1%–0.2% of participants used answer level 5. Severely
ill people may not be able to participate in the questionnaire, may decline to participate, or may be
absent from home. Research is needed to evaluate EQ-5D-5L in clinical patient populations with severe
and extreme problems. Of the potential 247 health states with a problem score ě20 in the 5L, only
six were observed in this total sample of 6074 people. In order to increase inclusion of participants
with extreme health problems, extension or supplements to the current sampling procedure may have
to be considered. It becomes clear that the increased discriminatory power of the EQ-5D-5L may, at
the same time, have drawbacks including lower numbers of extreme health states being observed.
This problem increases in relevance when samples from the general population are used and selection
bias toward the omission of severely ill participants is not accounted for.
Slight problems with pain/discomfort were reported less often, whereas slight problems with
anxiety/depression increased over the 3-year period. However, the differences among all 3 years were
not significant. In line with previous and other studies [18,23], pain/discomfort is the dimension with
most problems.
Despite an optimal health state, VAS values deteriorated continuously from 97.8 in the age group
10–19 years to 81.4 in the age group ě80 years. One explanation for this discrepancy are differences in
HRQoL coverage of VAS and the five dimensions of the EQ-5D. The daily activities of an 80 year old,
to a very high probability, are not the same as the daily activities of someone in his/her 40 s. These
participants likely adapted their activities to their bodily constitutions. Therefore, the 80 year old’s
ability to fulfill all current daily activities may still constitute “no problems”, while his/her overall
fitness has actually depreciated over time. Owing to its dimension-free character, the VAS can pick up
dimension-unspecific elements of HRQoL status.
Overall variation in results for health state descriptions and valuations, including
sociodemographic parameters and chronic diseases, across the three surveys was low. Concerning
underlying socioeconomic variables, we observed a trend toward a higher level of medium and high
education (p < 0.002), but it could not be determined to what degree, or if at all, this was caused by
lowered entry barriers and reduced standards for medium and high education.
4.1. Morbidity
Our results for the prevalence of diseases—qualitative and quantitative—were statistically not
significantly different among the three surveys. Of the five diseases under evaluation, hypertension
had the highest prevalence with 6.1%. This is in sharp contrast to Balijepalli et al. [24], who stated that
54.8% of adult primary care attendees suffer from high blood pressure. The primary care setting may
be too restrictive. From a nationwide perspective Neuhauser et al. [25] conclude that between 2008
and 2011 around one third of the adult German population (age 18 to 79) had high blood pressure.
This discrepancy may partly be rooted in age differences as our study included respondents from
14 years on, and, compared with the German population, has relatively low shares of respondents
aged 80 years and older who are likely to suffer from some chronic disease. Furthermore, it is known
that the prevalence of hypertension is underestimated by self-report for the disease [26]. Our results
for the prevalence of Rheumatism and Diabetes differ, too. 1.6% of our participants claim to have
rheumatism, while the actual prevalence seems to be around 2.5% [27]. The actual prevalence of
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diabetes is around 7% [28], while our surveys include 3.2% of participants who claim to suffer
from diabetes. Thus, we would highly recommend clinical testing for evaluating respective disease
prevalence. More importantly, we found out that the number of diseases cumulatively reduce VAS
means. The presence of two diseases has a stronger influence on VAS mean reduction than any
of the most prevalent diseases under evaluation (e.g., diabetes ´24.4 vs. presence of two diseases
´26.9). The reduction of VAS means increases rapidly to ´40 for three diseases but the confidence
intervals widen due to decreasing number of observations. Compared to Heyworth et al. [29] (UK) the
VAS-means stratified by number of diseases mirror each other well (69.4, 63.3, 56.7, 40.7 vs. 66.9, 57.4,
44.3, 37.2 for 1, 2, 3 and 4 diseases respectively). Age and disease differences (asthma, COPD, Diabetes,
Hypertension, ischemic heart disease and stroke) may partly explain the remaining divergences.
Considering evidence of both studies it can be concluded that multimorbidity leads to patients with
special medical needs.
4.2. Comparison with Other Studies
A number of baseline variables (aggregated sample) in this study can also be compared with
earlier studies using the EQ-5D-3L in yearly population surveys by Wort & Bild Verlag from 2006 to 2011
(n = 11,177) [18]. The gender distribution in these surveys was comparable to our study. Low education
decreased from 44.0% (2006–2011) to 39.7% (2012–2014), while medium and high education increased
from 56.0% to 60.4% respectively. Fewer people lived with a partner (68.42% vs. 58.6%). The prevalence
of disease fell among all categories. The strongest reduction was seen for musculoskeletal disease,
which dropped from around 7.2% to 4.4% in our evaluation. Presence of chronic disease fell from
24.5% to 21.6%.
Comparable data for the EQ-5D-3L from 2006 and 2007 showed that the number of observed health
states was 49, whereas the maximum number of possible health states was 243 [12]. This resembles
a ratio from observed to possible states of around 1:5. The same ratio increased to around 1:12 in
our study.
In a representative sample of the general German population of 2011 (n = 2469), Hinz et al. [30]
identified 210 distinct health states in the 5L version, about a fifth less than the number of states
identified in this study in a sample more than twice as large. Hinz et al. also reported that 47.5% (mean
age 50.5 years) of the sample were in the optimal health state, which is lower than in this study but can
be partly attributed to the higher mean age. The distribution of VAS values in the same age categories
was quite stable, and the decline in VAS values by increasing age [31] resembles the proportions from
2006 [19]. Age-related deterioration in VAS values and health status is seen in other studies [32–34]
for men and women as well as people with problems and those without. Our participants in the
best health state showed an average VAS score of 91.9. This score is around 4 points higher than the
88 points in the survey from 2006 [19]. From age group 70–79 to age group 80+ years, a significant
decrease in VAS means can be observed for those people who reported problems. Compared with
Koenig et al. [35], who did not differentiate between genders, our current VAS mean of 92.2–95.1 for
the age group 20–29 years (n = 842) is significantly higher than their VAS mean of 85.4 for the age
group 18–24 years (n = 263). Mielck et al. [19] also reported lower VAS means for the youngest age
group as well as overall (80.0 vs. 84.3). VAS means seem to drop to around or below 60 for the highest
age group in all three studies. Mielck et al. [19] stated that 60.6% of participants were in the optimal
health state (11111), which is slightly less than in our sample (61.6%).
It was difficult to find other consecutive, representative cross-sectional studies for Germany that
used the EQ-5D-5L. A recent study by Steiber [36], incorporating the SF-12, reported that physical
fitness decreased and fluid intelligence increased in a representative sample of older people from 2006
to 2012. Although fluid intelligence was not measured in our study, we saw an increase in people with
no problems among all dimensions. A small fall was observed for people with no mobility problems
from 27.4% (2012) and 27.9% (2013) to 27% (2014).
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Limitations of this study include possible selection bias found in general population surveys.
Clinical populations with severe or extreme problems were not observed. Sufficient data for severe
or extreme problems are generally hard to come by using the current selection process. Furthermore,
self-reporting of disease included no form of verification. True disease affliction may differ from
self-reported answers. Yet, for the part of the general population that can be addressed by surveys,
this study delivered useful norm data for three consecutive years. Respective evaluations are rare but
are needed to determine the health status of the general German population.
5. Conclusions
Contrary to assumed stability, a small but significant trend toward better health was observed in
three yearly surveys from 2012 to 2014. Remaining variation in results for health state descriptions
and valuations, including sociodemographic parameters and chronic diseases, was low. The number
of present diseases reduced VAS results cumulatively. The participant selection process, based on
a random-route procedure, failed to deliver sufficient data for participants with severe or extreme
problems. Given the extended size of the pooled sample, health state valuations identified here may
serve as broadly founded reference values for the general German population.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/13/3/343, Table S1:
Representativity of data, Table S2: Age distribution, VAS values, aggregated samples 2012, 2013, and 2014.
Author Contributions: Manuel B. Huber drafted the manuscript, analyzed and interpreted the data.
Peter Reitmeir conducted statistical analyses, helped to evaluate the data, and contributed to the manuscript.
Martin Vogelmann supplied the data and contributed to the manuscript. Reiner Leidl supervised and directed the
study, contributed to data interpretation and drafting of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
The following abbreviations are used in this manuscript:
ANOVA Analysis of variance
HRQoL Health-related quality of life
VAS Visual Analog Scale
References
1. EuroQol Group. EuroQol—A new facility for the measurement of health-related quality of life. Health Policy
1990, 16, 199–208.
2. PubMed Health (Internet). Bethesda (MD): National Library of Medicine (U.S.). Available online:
http://www.ncbi.nlm.nih.gov/pubmedhealth/ (accessed on 10 January 2016).
3. Herdman, M.; Gudex, C.; Lloyd, A.; Janssen, M.; Kind, P.; Parkin, D.; Bonsel, G.; Badia, X. Development and
preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 2011, 20, 1727–1736.
[CrossRef] [PubMed]
4. Kim, T.H.; Jo, M.W.; Lee, S.I.; Kim, S.H.; Chung, S.M. Psychometric properties of the EQ-5D-5L in the general
population of South Korea. Qual. Life Res. 2013, 22, 2245–2253. [CrossRef] [PubMed]
5. Jia, Y.X.; Cui, F.Q.; Li, L.; Zhang, D.L.; Zhang, G.M.; Wang, F.Z.; Gong, X.H.; Zheng, H.; Wu, Z.H.;
Miao, N.; et al. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.
Qual. Life Res. 2014, 23, 2355–2363. [CrossRef] [PubMed]
6. Feng, Y.; Devlin, N.; Herdman, M. Assessing the health of the general population in England: How do the
three- and five-level versions of EQ-5D compare? Health Qual. Life Outcomes 2015, 13. [CrossRef] [PubMed]
7. Janssen, M.F.; Pickard, A.S.; Golicki, D.; Gudex, C.; Niewada, M.; Scalone, L.; Swinburn, P.; Busschbach, J.
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups:
A multi-country study. Qual. Life Res. 2013, 22, 1717–1727. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2016, 13, 343 11 of 12
8. Agborsangaya, C.B.; Lahtinen, M.; Cooke, T.; Johnson, J.A. Comparing the EQ-5D 3L and 5L: Measurement
properties and association with chronic conditions and multimorbidity in the general population. Health Qual.
Life Outcomes 2014, 12. [CrossRef] [PubMed]
9. Dolan, P. Modeling valuations for EuroQol health states. Med. Care 1997, 35, 1095–1108. [CrossRef] [PubMed]
10. Greiner, W.; Claes, C.; Busschbach, J.J.; von der Schulenburg, J.M. Validating the EQ-5D with time trade off
for the German population. Eur. J. Health Econ. 2005, 6, 124–130. [CrossRef] [PubMed]
11. Burstrom, K.; Sun, S.; Gerdtham, U.G.; Henriksson, M.; Johannesson, M.; Levin, L.A.; Zethraeus, N. Swedish
experience-based value sets for EQ-5D health states. Qual. Life Res. 2014, 23, 431–442. [CrossRef] [PubMed]
12. Leidl, R.; Reitmeir, P. A value set for the EQ-5D based on experienced health states: Development and testing
for the German population. Pharmacoeconomics 2011, 29, 521–534. [CrossRef] [PubMed]
13. Oppe, M.; Devlin, N.J.; van Hout, B.; Krabbe, P.F.; de Charro, F. A program of methodological research to
arrive at the new international EQ-5D-5L valuation protocol. Value Health 2014, 17, 445–453. [CrossRef]
[PubMed]
14. EuroQol Group. EQ-5D-5L Value Sets. Available online: http://www.euroqol.org/about-eq-5d/valuation-
of-eq-5d/eq-5d-5l-value-sets.html (accessed on 10 January 2016).
15. Sainani, K.L. Dealing with longitudinal data. PM R 2015, 7, 649–653. [CrossRef] [PubMed]
16. Yang, Y.; Herting, J.R.; Choi, J. Obesity, metabolic abnormality, and health-related quality of life by gender:
A cross-sectional study in Korean adults. Qual. Life Res. 2015. [CrossRef] [PubMed]
17. Garin, N.; Olaya, B.; Moneta, M.V.; Miret, M.; Lobo, A.; Ayuso-Mateos, J.L.; Haro, J.M. Impact of
multimorbidity on disability and quality of life in the Spanish older population. PLoS ONE 2014, 9, e111498.
[CrossRef] [PubMed]
18. Mielck, A.; Vogelmann, M.; Leidl, R. Health-related quality of life and socioeconomic status: Inequalities
among adults with a chronic disease. Health Qual. Life Outcomes 2014, 12. [CrossRef] [PubMed]
19. Mielck, A.; Vogelmann, M.; Schweikert, B.; Leidl, R. Health status of adults in Germany: Results from
a representative survey using the EuroQol 5D (EQ-5D). Gesundheitswesen 2010, 72, 476–486. [CrossRef]
[PubMed]
20. Wickham, H. Ggplot2: Elegant Graphics for Data Analysis; Springer: New York, NY, USA, 2009.
21. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing:
Vienna, Austria, 2015.
22. Walters, S.J.; Brazier, J.E. Comparison of the minimally important difference for two health state utility
measures: EQ-5D and SF-6D. Qual. Life Res. 2005, 14, 1523–1532. [CrossRef] [PubMed]
23. Abdin, E.; Subramaniam, M.; Vaingankar, J.A.; Luo, N.; Chong, S.A. Measuring health-related quality of life
among adults in Singapore: Population norms for the EQ-5D. Qual. Life Res. 2013, 22, 2983–2991. [CrossRef]
[PubMed]
24. Balijepalli, C.; Bramlage, P.; Losch, C.; Zemmrich, C.; Humphries, K.H.; Moebus, S. Prevalence and control of
high blood pressure in primary care: Results from the German Metabolic and Cardiovascular Risk Study
(GEMCAS). Hypertens. Res. 2014, 37, 580–584. [CrossRef] [PubMed]
25. Neuhauser, H.K.; Adler, C.; Rosario, A.S.; Diederichs, C.; Ellert, U. Hypertension prevalence, awareness,
treatment and control in Germany 1998 and 2008–2011. J. Hum. Hypertens. 2015, 29, 247–253. [CrossRef]
[PubMed]
26. Goldman, N.; Lin, I.F.; Weinstein, M.; Lin, Y.H. Evaluating the quality of self-reports of hypertension and
diabetes. J. Clin. Epidemiol. 2003, 56, 148–154. [CrossRef]
27. Fuchs, J.; Rabenberg, M.; Scheidt-Nave, C. Prevalence of selected musculoskeletal conditions in
Germany: Results of the German Health Interview and Examination Survey for Adults (DEGS1).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013, 56, 678–686. [CrossRef] [PubMed]
28. Heidemann, C.; Du, Y.; Schubert, I.; Rathmann, W.; Scheidt-Nave, C. Prevalence and temporal trend of known
diabetes mellitus: Results of the German Health Interview and Examination Survey for Adults (DEGS1).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013, 56, 668–677. [CrossRef] [PubMed]
29. Heyworth, I.T.; Hazell, M.L.; Linehan, M.F.; Frank, T.L. How do common chronic conditions affect
health-related quality of life? Br. J. Gen. Pract. 2009, 59, e353–e358. [CrossRef] [PubMed]
30. Hinz, A.; Kohlmann, T.; Stobel-Richter, Y.; Zenger, M.; Brahler, E. The quality of life questionnaire EQ-5D-5L:
Psychometric properties and normative values for the general German population. Qual. Life Res. 2014, 23,
443–447. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2016, 13, 343 12 of 12
31. Lopez-Otin, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell 2013, 153,
1194–1217. [CrossRef] [PubMed]
32. Luthy, C.; Cedraschi, C.; Allaz, A.F.; Herrmann, F.R.; Ludwig, C. Health status and quality of life: Results
from a national survey in a community-dwelling sample of elderly people. Qual. Life Res. 2015, 24, 1687–1696.
[CrossRef] [PubMed]
33. Shiroiwa, T.; Fukuda, T.; Ikeda, S.; Igarashi, A.; Noto, S.; Saito, S.; Shimozuma, K. Japanese population norms
for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual. Life Res. 2015. [CrossRef] [PubMed]
34. Konig, H.H.; Heider, D.; Lehnert, T.; Riedel-Heller, S.G.; Angermeyer, M.C.; Matschinger, H.; Vilagut, G.;
Bruffaerts, R.; Haro, J.M.; de Girolamo, G.; et al. Health status of the advanced elderly in six European
countries: Results from a representative survey using EQ-5D and SF-12. Health Qual. Life Outcomes 2010, 8.
[CrossRef]
35. Konig, H.H.; Bernert, S.; Angermeyer, M.C. Health Status of the German population: Results of
a representative survey using the EuroQol questionnaire. Gesundheitswesen 2005, 67, 173–182. [PubMed]
36. Steiber, N. Population aging at cross-roads: Diverging secular trends in average cognitive functioning and
physical health in the older population of Germany. PLoS ONE 2015, 10, e0136583. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons by Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
